Benlysta (belimumab) is a prescription drug that treats lupus by reducing the number of certain proteins in your blood that attack your body. Your response to this drug may vary based on your medical ...
Benlysta is a human monoclonal antibody that was approved for the treatment of lupus in adults by the U.S. Food and Drug Administration (FDA) in 2011 and for lupus nephritis in adults in 2020.
MONDAY, June 30, 2025 (HealthDay News) -- The U.S. Food and Drug Administration has approved an autoinjector of Benlysta (belimumab) for subcutaneous injection in patients ≥5 years of age with active ...
The 200mg single-dose prefilled autoinjector allows pediatric patients to receive SLE treatment at home via SC administration. The Food and Drug Administration (FDA) has approved Benlysta (belimumab) ...
Benlysta is now the first and only biologic approved for adults and children who have lupus or lupus nephritis Please see US Prescribing Information for Benlysta. This is the first FDA-approved ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results